843 results on '"Bauer, Todd W."'
Search Results
102. Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma
103. Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy
104. Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment
105. Assessment of the Lymph Node Status in Patients Undergoing Liver Resection for Intrahepatic Cholangiocarcinoma: the New Eighth Edition AJCC Staging System
106. Correction to: Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery
107. ASO Visual Abstract: Long-Term Recurrence-Free and Overall Survival Differ Based on Common, Proliferative, and Inflammatory Subtypes After Resection of Intrahepatic Cholangiocarcinoma
108. Lymph Node Examination and Patterns of Nodal Metastasis Among Patients with Left- Versus Right-Sided Intrahepatic Cholangiocarcinoma After Major Curative-Intent Resection
109. Higher Tumor Burden Status Dictates the Impact of Surgical Margin Status on Overall Survival in Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma
110. Long-Term Recurrence-Free and Overall Survival Differ Based on Common, Proliferative, and Inflammatory Subtypes After Resection of Intrahepatic Cholangiocarcinoma
111. Abstract C054: Hypoxia promotes a durable epithelial-mesenchymal transition in pancreas cancer through a histone methylation-MAPK signaling axis
112. Principles of Surgical Oncology
113. A histone methylation-MAPK signaling axis drives durable epithelial-mesenchymal transition in hypoxic pancreas cancer
114. ASO Visual Abstract: Application of Hazard Function to Investigate Recurrence of Intrahepatic Cholangiocarcinoma After Curative-Intent Liver Resection: A Novel Approach to Characterize Recurrence
115. Surgical Management of Advanced Gastrointestinal Stromal Tumors: An International Multi-Institutional Analysis of 158 Patients
116. Co-Treatment with Panitumumab and Trastuzumab Augments Response to the MEK Inhibitor Trametinib in a Patient-Derived Xenograft Model of Pancreatic Cancer
117. Timing of disease occurrence and hepatic resection on long‐term outcome of patients with neuroendocrine liver metastasis
118. Performance of prognostic scores and staging systems in predicting long‐term survival outcomes after surgery for intrahepatic cholangiocarcinoma
119. The impact of extrahepatic disease among patients undergoing liver‐directed therapy for neuroendocrine liver metastasis
120. Morbidity and Mortality After Gastrectomy: Identification of Modifiable Risk Factors
121. Adjuvant Trametinib Delays the Outgrowth of Occult Pancreatic Cancer in a Mouse Model of Patient-Derived Liver Metastasis
122. A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis
123. Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection
124. Application of Hazard Function to Investigate Recurrence of Intrahepatic Cholangiocarcinoma After Curative-Intent Liver Resection: A Novel Approach to Characterize Recurrence
125. Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma
126. ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer
127. UTILITY OF ENDOSCOPIC ULTRASOUND IN GASTRIC CANCER STAGING
128. A 6‐day clinical pathway after a pancreaticoduodenectomy is feasible, safe and efficient
129. Inhibition of the Growth of Patient-Derived Pancreatic Cancer Xenografts with the MEK Inhibitor Trametinib Is Augmented by Combined Treatment with the Epidermal Growth Factor Receptor/HER2 Inhibitor Lapatinib
130. Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements
131. Dynamic Prediction of Survival After Curative Resection of Intrahepatic Cholangiocarcinoma:A Landmarking-Based Analysis
132. Management and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: An international multi‐institutional analysis
133. The effect of preoperative chemotherapy treatment in surgically treated intrahepatic cholangiocarcinoma patients—A multi‐institutional analysis
134. The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma
135. Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration
136. Readmission After Liver Resection for Intrahepatic Cholangiocarcinoma: a Multi-Institutional Analysis
137. Morbidity and Mortality of Pancreaticoduodenectomy for Benign and Premalignant Pancreatic Neoplasms
138. Adherence to Guidelines for Adjuvant Imatinib Therapy for GIST: A Multi-institutional Analysis
139. Minimally Invasive Resection of Choledochal Cyst: a Feasible and Safe Surgical Option
140. Prognostic impact of perineural invasion in intrahepatic cholangiocarcinoma: multicentre study
141. Tu1188: COMPARISON OF NATIONAL AND INTERNATIONAL GUIDELINES IN PREDICTING AN APPROPRIATE NEED OF SURGICAL RESECTION OF INTRADUCTAL PAPILLARY MUCOSAL NEOPLASMS
142. A Nomogram to Predict Disease-Free Survival After Surgical Resection of GIST
143. 619 DEVELOPMENT OF AN ARTIFICIAL INTELLIGENCE BASED MODEL TO PREDICT EARLY RECURRENCE OF NEUROENDOCRINE LIVER METASTASIS FOLLOWING RESECTION
144. Automated biophysical classification of apoptotic pancreatic cancer cell subpopulations by using machine learning approaches with impedance cytometry
145. Genomic Profiling of Intrahepatic Cholangiocarcinoma: Refining Prognosis and Identifying Therapeutic Targets
146. Open Versus Minimally Invasive Resection of Gastric GIST: A Multi-Institutional Analysis of Short- and Long-Term Outcomes
147. Tumor Size Predicts Vascular Invasion and Histologic Grade Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma
148. A multi-institutional analysis of elderly patients undergoing a liver resection for intrahepatic cholangiocarcinoma
149. Proposed modification of the eighth edition of the AJCC staging system for intrahepatic cholangiocarcinoma
150. Launch of the PANC-PALS Consortium
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.